These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32548548)

  • 1. Plasminogen activation in the musculoskeletal acute phase response: Injury, repair, and disease.
    Gibson BHY; Duvernay MT; Moore-Lotridge SN; Flick MJ; Schoenecker JG
    Res Pract Thromb Haemost; 2020 May; 4(4):469-480. PubMed ID: 32548548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintaining the balance: the critical role of plasmin activity in orthopedic surgery injury response.
    Moore-Lotridge SN; Hajdu KS; Hou BQ; Gibson BHY; Schoenecker JG
    J Thromb Haemost; 2023 Oct; 21(10):2653-2665. PubMed ID: 37558131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic regulation and pathologic disorders of fibrinolysis.
    Francis CW; Marder VJ
    Hum Pathol; 1987 Mar; 18(3):263-74. PubMed ID: 3546075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H
    Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.
    Kwieciński J; Josefsson E; Jin T
    Inflamm Res; 2011 Nov; 60(11):1021-9. PubMed ID: 21786185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.
    Cole HA; Ohba T; Nyman JS; Hirotaka H; Cates JM; Flick MJ; Degen JL; Schoenecker JG
    Arthritis Rheumatol; 2014 Aug; 66(8):2222-33. PubMed ID: 24664548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
    Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
    Sakharov DV; Lijnen HR; Rijken DC
    J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes.
    Hassan MM; Sharmin S; Kim HJ; Hong ST
    Circ Res; 2021 Feb; 128(3):386-400. PubMed ID: 33292062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.